HomeMLTX • NASDAQ
add
MoonLake Immunotherapeutics
Previous close
$40.69
Day range
$39.86 - $42.05
Year range
$36.52 - $58.26
Market cap
2.56B USD
Avg Volume
359.20K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 49.58M | 229.90% |
Net income | -45.60M | -513.20% |
Net profit margin | — | — |
Earnings per share | -0.72 | -500.00% |
EBITDA | -48.28M | -229.14% |
Effective tax rate | -0.09% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 448.03M | -12.32% |
Total assets | 477.93M | -9.23% |
Total liabilities | 24.54M | 88.08% |
Total equity | 453.39M | — |
Shares outstanding | 63.28M | — |
Price to book | 5.75 | — |
Return on assets | -24.89% | — |
Return on capital | -25.96% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -45.60M | -513.20% |
Cash from operations | -48.47M | -292.68% |
Cash from investing | -147.33M | -226.07% |
Cash from financing | 150.71K | -99.47% |
Net change in cash | -195.23M | -246.79% |
Free cash flow | -33.34M | -305.45% |
About
Founded
2020
Headquarters
Website
Employees
100
